Nexalin Technology (NXL) Share-based Compensation (2021 - 2026)
Nexalin Technology (NXL) posted quarterly Share-based Compensation of $478611.0 for Q1 2026, down 24.85% year-over-year from $636844.0 in Q1 2025, and down 42.44% quarter-over-quarter from $831529.0 in Q4 2025.
Nexalin Technology (NXL) Share-based Compensation (2021 - 2026) Analysis & Trends
Nexalin Technology's Share-based Compensation history runs 6 years deep, the most recent figure standing at $478611.0 for Q1 2026.
- In Q1 2026, Share-based Compensation fell 24.85% year-over-year to $478611.0; the TTM figure through Mar 2026 stood at $3.0 million (down 26.54% YoY), while the FY2025 annual figure was $3.1 million, down 12.28% from the prior year.
- Share-based Compensation for Q1 2026 stood at $478611.0, down from $831529.0 in the prior quarter.
- The five-year high for Share-based Compensation was $1.6 million in Q4 2024, with the low at $88388.0 in Q2 2023.
- The 5-year median for Share-based Compensation is $393447.0 (2024), against an average of $569678.9.
- The sharpest annual moves came in 2022 and 2024: Share-based Compensation slumped 87.67% in 2022, then soared 471.86% in 2024.
- Nexalin Technology's Share-based Compensation stood at $184291.0 in 2022, then jumped by 47.24% to $271342.0 in 2023, then jumped by 471.86% to $1.6 million in 2024, then tumbled by 46.41% to $831529.0 in 2025, then plunged by 42.44% to $478611.0 in 2026.
- Business Quant data shows NXL's Share-based Compensation at $478611.0 in Q1 2026, $831529.0 in Q4 2025, and $1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 7.00 Mn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 87.00 Mn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 42.20 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 39.00 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 45.00 Mn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 94.15 Mn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 12.80 Mn |
| 10 | Nexalin Technology | 6.98 Mn | 5.97 Mn | 8,897.00 | 408,387.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 408,387.00 |
| Jun 30, 2026 | 408,387.00 |
| Mar 31, 2026 | 478,611.00 |
| Mar 31, 2026 | 478,611.00 |
| Dec 31, 2025 | 831,529.00 |
| Dec 31, 2025 | 831,529.00 |
| Sep 30, 2025 | 1.08 Mn |
| Sep 30, 2025 | 1.08 Mn |
| Jun 30, 2025 | 572,100.00 |
| Jun 30, 2025 | 572,100.00 |
| Mar 31, 2025 | 636,844.00 |
| Mar 31, 2025 | 636,844.00 |
| Dec 31, 2024 | 1.55 Mn |
| Dec 31, 2024 | 1.55 Mn |
| Sep 30, 2024 | 1.54 Mn |
| Sep 30, 2024 | 1.54 Mn |
| Jun 30, 2024 | 308,283.00 |
| Jun 30, 2024 | 308,283.00 |
| Mar 31, 2024 | 161,349.00 |
| Mar 31, 2024 | 161,349.00 |